Costs of not eradicating measles.
American Journal of Public HealthPublished 1 July 1985Open access
A R Hinman, K. J. Bart, D R Hopkins
Citations10
SJR quartileQ1
SJR score1.93
SNIP1.60
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
Abstract
Costs of not eradicating measles. A R Hinman, K J Bart, and D R HopkinsCopyRight https://doi.org/10.2105/AJPH.75.7.713 Published Online: October 07, 2011
Keywords
Social Sciences
American Journal of Public HealthBenefits, risks and costs of immunization for measles, mumps and rubella.
192 Citations1985Craigc . White, Jeffrey P. Koplan +1 more
Compared reductions in disease-associated complications, sequelae, and deaths are gained with an immunization program, and savings realized due to the use of combination rather than single antigen vaccine total nearly $60 million.
The LancetTHE CASE FOR GLOBAL MEASLES ERADICATION
84 Citations1982D R Hopkins, JeffreyP. Koplan +2 more
The feasibility of a measles eradication programme is suggested by the success of smallpox eradication, the availability of a heat-stable, cheap, and effective vaccine, and the fact that interruption of measles transmission has been achieved in some places.